1-3 of 3
Elaina Mann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 927: Pretreatment and serial plasma assessments of EGFR mutations in NSCLC patients treated with rociletinib (CO-1686)

Free
Jonathan W. Goldman, Chris Karlovich, Elaina Mann, Lindsey Rolfe, Shannon Matheny, Darrin Despain, Philipp Angenendt, Claudia Stamm, Heather A. Wakelee, Jean-Charles Soria, Benjamin Solomon, D. R. Camidge, Rafal Dziadziuszko, Leora Horn, Shirish Gadgeel, Mitch Raponi, Andrew R. Allen, Lecia V. Sequist
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 927.
https://doi.org/10.1158/1538-7445.AM2015-927
Published: 01 August 2015
View articletitled, Abstract 927: Pretreatment and serial plasma assessments of EGFR mutations in NSCLC patients treated with rociletinib (CO-1686)
Journal Articles

Abstract 5587: Serial monitoring of EGFR mutations in plasma and evaluation of EGFR mutation status in matched tissue and plasma from NSCLC patients treated with CO-1686

Free
Rafal Dziadziuszko, Chris Karlovich, Wei Wen, Jong-Mu Sun, Sean Chien, Elaina Mann, Patrick O'Donnell, Philipp Angenendt, Heather Wakelee, Leora Horn, David Spigel, Lecia Sequist, Jean-Charles Soria, Benjamin Solomon, D. Ross Camidge, Jonathan Goldman, Shirish Gadgeel, Mitch Raponi, Andrew Allen, Lin Wu, Keunchil Park
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5587.
https://doi.org/10.1158/1538-7445.AM2014-5587
Published: 01 October 2014
View articletitled, Abstract 5587: Serial monitoring of EGFR mutations in plasma and evaluation of EGFR mutation status in matched tissue and plasma from NSCLC patients treated with CO-1686
Journal Articles

Ligand-like Effects Induced by Anti-c-erbB-2 Antibodies Do Not Correlate with and Are Not Required for Growth Inhibition of Human Carcinoma Cells

Free
Laura K. Shawver, Elaina Mann, Susan S. Elliger, Teresa C. Dugger, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (1994) 54 (5): 1367–1373.
Published: 01 March 1994
View articletitled, Ligand-like Effects Induced by Anti-c-erbB-2 Antibodies Do Not Correlate with and Are Not Required for Growth Inhibition of Human Carcinoma Cells
Open the PDF for Ligand-like Effects Induced by Anti-c-erbB-2 Antibodies Do Not Correlate with and Are Not Required for Growth Inhibition of Human Carcinoma Cells in another window